A carregar...
Recent survival trends in diffuse large B‐cell lymphoma––Have we made any progress beyond rituximab?
BACKGROUND: Population‐based studies previously showed an improvement in overall survival (OS) for patients with diffuse large B‐cell lymphoma (DLBCL) who received chemoimmunotherapy with rituximab. However, there is limited data (especially at the population level) that show a similar trend in OS i...
Na minha lista:
| Publicado no: | Cancer Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7402846/ https://ncbi.nlm.nih.gov/pubmed/32558356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3237 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|